Amping up With PemJAK

Clinical trial NCT07283822 · RECRUITING

Trial details

NCT number: NCT07283822
Sponsor: Seda S. Tolu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Hodgkin Disease Lymphoma Non-Hodgkin Lymphoma Refractory/ Relapsed Hodgkin Disease Recurrent Gray Zone Lymphoma Peripheral T-cell Lymphoma Cutaneous T-Cell Lymphomas Primary Mediastinal B Cell Lymphoma

Start date: 2025-12-03
Primary completion: 2028-01-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.